Transplanting Lungs From Uncontrolled Donation After Circulatory Death: An Early Phase Clinical Trial
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 24
- 试验地点
- 2
- 主要终点
- Incidence of Primary Graft Dysfunction (PDG) Grade III
研究概览
简要总结
The study team developed an uncontrolled donation after circulatory death (uDCD) protocol that preserves lungs for just over 3 hours after death using positive end expiratory pressure (PEEP) and supplemental oxygen. The study will assess lung uDCD program safety by continuous review of operations/clinical records from each case activation and transplantation. Attrition outcomes include rates of initial and continued lung preservation, donation authorization, lung recovery, passing ex-vivo lung perfusion (EVLP) performance testing, and lung transplantation. Planned viability assessments also include macroscopic determination, radiology (X-ray), and fiber optic bronchoscopy before initiating EVLP. We expect ~50% of lungs assessed with EVLP will be transplanted to meet sustainability targets. Safety outcomes include the primary outcome, primary graft dysfunction (PGD) grade III at 72 hours, and secondarily survival one year after transplantation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients waiting for lung transplants
- •Willing to participate in the research study
排除标准
- •Unable to be followed for 1 year after transplantation
- •Unable to provide written informed consent to participate in the research (or designate a surrogate)
研究组 & 干预措施
Lung uDCD Protocol
干预措施: Lung uDCD Protocol (Device)
结局指标
主要结局
Incidence of Primary Graft Dysfunction (PDG) Grade III
时间窗: 72 Hours Post-Transplant
PGD is measured 72 hours after transplantation and defined according to the International Society for Heart and Lung Transplantation (ISHLT) criteria: partial pressure of arterial oxygen divided by the fraction of inspired oxygen (Pa02/FI02) \< 200 mm Hg.
次要结局
- Number of Participants who Required Normothermic Extracorporeal Membrane Oxygenation (nECMO)(1 Year Post-Transplant)
- Incidence of Re-Transplantation(1 Year Post-Transplant)
- Overall Survival(1 Year Post-Transplant)
